Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Communiqué de presse : Dupixent : Présentation de nouvelles données positives de phase III dans le traitement de l’urticaire chronique spontanée...
Press Release: Dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria to be presented at ACAAI Dupixent late-breaking...
Dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria to be presented at ACAAI Dupixent...
Communiqué de presse : Sanofi et CD&R s’allient pour soutenir les ambitions d’Opella dans la santé grand public Sanofi et CD&R s’allient...
Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare Sanofi and CD&R enter...
Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare Sanofi and CD&R partner to fuel Opella’s...
Communiqué de presse : Sanofi et Orano Med unissent leurs forces pour développer des radiothérapies internes vectorisées de nouvelle génération...
Press Release: Sanofi and Orano join forces to develop next-generation radioligand medicines Sanofi and Orano join forces to develop...
Sanofi and Orano join forces to develop next-generation radioligand medicines Paris, October 17, 2024. Sanofi...
Sanofi: Information concerning the total number of voting rights and shares - September 2024 Information concerning the total number of voting...
Sanofi: Informations relatives au nombre de droits de vote et d'actions - SEPTEMBRE 2024 Informations relatives au nombre total de droits de...
Press Release: Sanofi in discussions to sell a controlling stake in Opella Sanofi in discussions to sell a controlling stake in Opella Paris...
Sanofi in discussions to sell a controlling stake in Opella Paris, October 11, 2024. Sanofi today announces...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관